Cross-disciplinary HIV Integrated Mental Health Support Intervention

NCT04833829 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 850

Last updated 2025-11-14

No results posted yet for this study

Summary

The proposed project seeks to develop and test an intervention to improve engagement in HIV and mental health care for young Black gay, bisexual and other men who have sex with men (YB-GBMSM) in Ryan White clinics.

Conditions

  • Human Immunodeficiency Virus
  • HIV Infections

Interventions

BEHAVIORAL

CHIMES Intervention

There are six components to the intervention: 1. Posters and other print materials to prompt providers and patients to discuss MH care engagement. 2. Brief verbal scripts to help HIV providers facilitate patient MH engagement and discuss barriers to MH utilization. 3. Expanded MH screening procedures, including at initial intake. 4. Case management, emphasizing MH care engagement. 5. Interactive trainings for all HIV providers on MH needs, screening/treatment, and barriers to MH service utilization specific to YB-GBMSM. 6. Regular case review meetings.

BEHAVIORAL

Standard of Care

The standard of care practices of referring patients to mental health services of the clinic during Months 1 - 12 of the study.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • Emory University

    lead OTHER

Principal Investigators

  • Sophia Hussen, MD, MPH · Emory University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04833829 on ClinicalTrials.gov